Introduction
ANCA Associated Vasculitides (AAV) is a group of autoimmune diseases comprising granulomatosis with polyangiitis (GPA), microscopic polyangiitis (MPA) and eosinophilic granulomatosis with polyangiitis (EGPA). They are characterized by autoantibodies against the neutrophil granule proteins proteinase 3 (PR3) or myeloperoxidase (MPO). These anti-neutrophil cytoplasmic antibodies, or ANCAs, can activate primed neutrophils to degranulate and produce reactive oxygen species (ROS) [1] , induce formation of Neutrophil Extracellular Traps (NETs) [2] and mediate the release of microparticles from polymorphonuclear leukocytes (PMNs) [3] . The exact mechanisms are not completely understood, but activation by ANCA seems to involve both the Fc portion of the antibody, as well as the Fab portion binding to its antigen on the neutrophil surface [4, 5] . However, there are also reports indicating that ANCA are internalized into the PMNs after binding, but the importance of this remains unknown [6] . Activation of neutrophils by ANCA is thought to play a major role in the pathogenesis and progress of these diseases. The pathogenicity of ANCA was first proved in vivo in a MPO-ANCA mouse model [7] . More recently, a PR3-ANCA mouse model has been described [8] . However, ANCA levels alone cannot predict relapses conclusively [9] , and there is an unmet need for better methods to assess the degree of disease and risk of relapse. Several attempts have been made to map both MPO [10] and PR3 for particularly harmful epitopes, and several conformational epitopes have been found [11, 12] . This information will be of importance for understanding the underlying mechanisms of these diseases and could also lead to better methods for assessing the disease course. Furthermore, IgG subclass specificity also matters for ANCA-mediated activation of the neutrophil [13] .
To our knowledge there are no systematic studies of PMNs from AAV patients and their response to ANCA stimulation. In this article we aimed to investigate if IgG from PR3-ANCA positive patients more or less easily activates neutrophils from AAV patients compared with neutrophils from healthy donors. Furthermore we characterize IgG purified from different patients to determine why some ANCA are more potent activators than others.
Material and Methods

Blood samples and patients
PMNs were isolated from PR3-ANCA positive AAV patients in stable clinical remission, as assessed by a Birmingham Vasculitis Activity Score (BVAS) of 0 [14] .
Serum samples for IgG purification were obtained from AAV patients with PR3-ANCA specificity and varying activity. The PR3-ANCA levels in a standard direct ELISA (Wieslab) ranged between 6-991 IU/mL (Table 1) . Healthy control (HC) IgG was used as negative controls in some assays. Written informed consent was retrieved from all donors and these studies were conducted with permission from the Ethical Review Board, Lund, Sweden. Logan, Utah, USA). IgG were concentrated to 2 mg/mL using Vivaspin 4 mL columns, 10,000 MWCO (Sartorium stedim biotech, Goettingen, Germany). The concentration was measured using a Nanodrop®. IgG aliquots were frozen at -20°C and they were spun down at 12,000 g for 10 min before use to avoid IgG aggregates in the assays.
PMN purification
Heparinized blood was collected and sedimented with 2 % Dextran T500
(Pharmacosmos, Holbaek, Denmark) in 0.9 % NaCl followed by density gradient centrifugation using Lymphoprep™ (Axis-Shield, Oslo, Norway) at 4°C. All subsequent steps were performed at this temperature. The remaining erythrocytes were lysed using water as hypotonic solution for a maximum of 30 s to leave PMNs intact.
Ionic concentration was restored by adding 1 volume 1.8 % NaCl.
Membrane PR3
Purified PMNs were stained with monoclonal antibodies against CD177-FITC (Serotech, Stockholm, Sweden) and PR3-Alexa647 (Eurodiagnostica, Malmö, Sweden) and analysed using a FACSCanto II (BD Biosciences, Stockholm, Sweden) as described previously [15] . Both percentage of PR3 positive cells and MFI of the positive cells were recorded.
ROS assay
Purified PMNs were adjusted to 2x10 6 (Fig. 1b) .
Degranulation assay
Purified PMNs were adjusted to 6x10 6 Release values are calculated as amount of protein in supernatant compared to total amount of protein (in supernatant + pellet) and reported as percentages.
Degranulation ELISA
5 different ELISAs, with supernatants and pellets from the degranulation assay, were performed to detect markers of different granula as has been described before [16] .
Albumin was used to detect secretory vesicles, gelatinase for gelatinase granula, lactoferrin for specific granula, MPO for azurophilic granula and PR3, mainly present in azurophilic granula but also others. 
NET formation assay
PMNs were isolated from a HC using Percoll density gradient separation (GE Healthcare, Uppsala, Sweden). Cell concentration was adjusted to 0.5x10 6 normalized to the same scale, setting the first value (incubated with 0 µg/mL PR3) to 100 % and last value (incubated with 2 µg/mL PR3) to 0 %. The PR3 concentration of the 50 % absorbance value for each IgG was read and the inverse value of this was interpreted as the affinity for PR3.
Statistical analysis
All statistical calculations were done using GraphPad Prism, version 6.0a. To compare groups, Mann-Whitney test was performed. For correlations, Spearman correlation coefficients were calculated.
Results
ANCA stimulation of PMNs
To (Fig. 1c-d) .
Degranulation was measured as percentage protein released from activated PMN in relation to total amount of protein detected. No significant differences were seen for any of the five measured granular proteins when comparing PMNs from AAV patients to HCs (Fig. 2a) . AAV IgG stimulated HC PMNs to a greater extent than IgG purified from HC sera (Fig. 2b) . The variation in the individual 10 AAV IgG preparations is shown in Fig. 3a -e. There were no significant differences between AAV and HC PMNs when studying individual AAV IgG stimulations.
The ability of the purified AAV IgG to induce NET formation in HC PMNs was determined by measuring the release of extracellular DNA using a fluorometric assay.
The ability to induce DNA release differed considerably between individual IgG preparations (Fig. 4a) . NET formation correlated with ROS production (intracellular ROS: rs=0.733, p=0.031 and extracellular ROS: rs=0.750, p=0.026) (Fig. 4b-c) .
To be able to compare the activation potential of the different AAV IgG preparations, 
Importance of ANCA levels, epitope specificity and affinity
A possible source of the variations in PMN activation capacity between different IgG preparations could be differences in the proportion of IgG being ANCA. However, when comparing results from the different functional assays performed above with ANCA levels, no significant correlations were found. This was true regardless if ANCA
was measured with a direct ELISA (data not shown) or with a capture ELISA (Fig. 5a ).
Commercially available PR3 ELISAs are designed to measure all epitope specificities and previous studies indicate that certain epitope specificities of PR3-ANCA are more pathogenic than others [11, 12] . To investigate this, we used 8 different mouse-human chimeric PR3 proteins previously developed by our group [17, 18] , and tested all IgGs seems to interfere with α1-antitrypsin binding and perhaps PR3's enzymatic activity [11, 12] . It includes the amino acids at position 35-39 and 72-78 in the PR3 molecule.
When combining the epitope ELISA results from HHm and Hm, we found significant correlations between reactivity to these chimeras and gelatinase release (rs=0.649, p=0.049) as well as lactoferrin release (rs=0.661, p=0.044, Fig. 5b-c) . No other significant correlations, including the activation score, were found. The epitope assay did not correlate with ROS and NET assays. No correlations were found when any of the eight individual constructs were correlated with any of the activation assays.
Another independent factor possibly influencing the activation of PMNs is affinity, which was measured using a competition ELISA. The IgGs were incubated with increasing concentrations of PR3 over night before tested in a PR3 ELISA. The results
show that PR3 affinity correlated with the activation score (rs=0.758, p=0.015, Fig. 5d ) as well as with total ROS production (luminol assay, rs=0.721, p=0.023, data not shown). Extracellular ROS alone, gelatinase and lactoferrin release had a tendency to correlate with affinity, but did not reach statistical significance. There was no correlation between affinity and ANCA levels (as measured by standard commercial PR3 ELISAs), emphasizing the importance of affinity for ANCA-mediated activation of neutrophils.
Discussion
In this study we aimed to decipher whether PMNs from AAV patients behave differently in response to ANCA stimulation compared with PMNs from HCs. We could see an increased intracellular ROS production in comparison with HC PMNs, whereas extracellular ROS production and degranulation were similar. The reason for increased ROS production is unknown, but we speculate that AAV patients' PMNs, even though in clinical remission, are exposed to a low-grade activation or priming. It has previously been shown that the cytokine profile of patients in active phase as well as remission phase is different from healthy donors [19] . There might be other explanations for this including intrinsic defects in the PMNs in AAV patients. AAV patients have an increased membrane expression of PR3 on their neutrophils and this has been connected to their higher degree of stimulation [20, 21] . However, PMNs from AAV patients in this study did not have significantly more PR3 on the surface than the HC PMNs. All patients received low dose glucocorticoids, but that this has any stimulatory effect on ROS production is unlikely, since glucocorticoids have been shown to reduce ROS production in PMNs [22] .
Why only intracellular and not extracellular ROS production differed remains elusive and it must be emphasized that our data is based on a small number of observations. The major ROS producing complex in phagocytes is the NADPH oxidase that resides in the plasma membrane (5 %) and in granule membranes (95 %) in neutrophils. Activation of NADPH oxidase in the plasma membrane leads to production of ROS that is released to the extracellular space. NADPH oxidase activation in the phagosome, by fusion of NADPH oxidase containing granules to the phagosome, is also a well-established defence mechanism, however there also exists intracellular non-phagosomal ROS production that seems to play an important roll for cell signalling and immune regulation [23] . It is also known that the assembly is somewhat different for extracellular and intracellular ROS production. For example the cytosolic component p40 phox is needed for intracellular, but not extracellular NADPH oxidase assembly [24] .
There is also evidence for involvement of different isoforms of PI3K and PLC in intracellular and extracellular ROS production, suggesting that different stimuli distinguish between these pathways [24, 25] . Moreover, ROS produced in one compartment can stimulate ROS production in another; so-called ROS induced ROS release. If the balance between the antioxidant and oxidant system is disturbed, excessive ROS could possibly initiate a self-perpetuating cycle leading to more damage [26] .
NET formation has previously been described to be dependent on ROS production [27] .
A role for NET formation in AAV has also been proposed since purified AAV IgG was found to induce more NET formation compared with HC IgG. In the same study it was also shown that AAV patients had more circulating NET-remnants, in terms of MPO-DNA complexes [2] . Our data support this finding since NET formation correlates with ROS release. Increased NET formation may be of importance for the development of ANCA, since NETs give rise to an increased antigen exposure for the immune system.
This could, in a pro-inflammatory milieu, supposedly break tolerance towards PR3 or MPO.
Our 10 different AAV IgGs exhibited different activation potential on PMNs. It is highly unlikely that this is due to differences in cytokine profiles [19] or different treatment regimens since the IgG was purified and soluble factors would be eliminated.
Moreover, the activity of the patients, as measured by BVAS, from whom the IgG was purified, did not influence the results in any of our assays. More surprisingly, ANCA levels assessed by standard direct PR3-ANCA or capture PR3-ANCA ELISAs did not correlate with any of our data. On the other hand, the antibody affinity for PR3 correlated with the activation score and this indicates that ANCA affinity is more important than ANCA levels for PMN activation. A previously identified epitope region in the PR3 molecule has been suggested to be of importance for AAV [11, 12] . In this study, we could confirm this, since degranulation correlated with reactivity to our chimeras that included this epitope. These results suggest that ANCA with certain epitope specificities are more potent PMN activators than others and that these epitopes are situated in the N-terminal region of PR3.
In conclusion, PMNs from AAV patients show an increased intracellular ROS production, but otherwise behave in a similar way as PMNs from HCs, opening the door for further studies within the field of cell signalling and involvement of ROS pathophysiology in these diseases. 
